Correlation between serum plasminogen activator inhibitor-1 level and carotidintima-media thickness, plaque stability in patients with obstructive sleep apnea hypopnea syndrome
CSTR:
Author:
Affiliation:

1.Department of Otorhinolaryngology,Baoji, Shaanxi 721008, China ;2.Department of Neurology, Baoji Municipal Central Hospital, Baoji, Shaanxi 721008, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [30]
  • | |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To investigate the serum plasminogen activator inhibitor-1 (PAI-1) level in patients with obstructive sleep apnea hypopnea syndrome (OSAHS) and its correlation with carotid intima-media thickness(CIMT) and plaque stability. Methods 167 patients who underwent polysomnography (PSG) in Baoji Municipal Central Hospital from July 2019 to January 2021 were enrolled and divided into control group (n=46), mild OSAHS group (n=15), moderate OSAHS group (n=39), and severe OSAHS group (n=67) according to sleep apnea-hypopnea index (AHI). Clinical data, PSG-related indexes, blood biochemical indicators, serum PAI-1 level, and CIMT were compared in the three groups. The relationship between CIMT and serum PAI-1 concentration in OSAHS patients was analyzed. According to CIMT, carotid plaque morphology, and ultrasonographic features, OSAHS patients were divided into simple OSAHS group (n=37), OSAHS stable plaque group (n=46), and OSAHS unstable plaque group (n=38). PAI-1 level in each group was compared. Multivariate Logistic regression analysis was used to explore the risk factors of carotid plaque stability in OSAHS patients. Results There were statistically significant differences between the four groups regarding sex, body mass index (BMI), hypertension, smoking history, AHI, oxygen depletion index (ODI), oxygen saturation less than 90% of the time in sleeping time (Ts90%), the lowest nocturnal oxygen saturation (L-SaO2), CIMT and serum PAI-1 level (P<0.05). Pearson correlation analysis showed that CIMT was positively correlated with PAI-1 level in OSAHS patients (r=0.675,P<0.001). The level of PAI-1 in the simple OSAHS group was 1.20 times, in the OSAHS stable plaque group was 1.79 times, and in the OSAHS unstable plaque group was 2.01 times that of the control group, and the difference had statistical significance (all P<0.05). Multiple linear regression suggested that CIMT was independently associated with AHI (B=0.019, P=0.001), PAI-1 (B=0.012, P<0.001), and low density lipoprotein cholesterol (LDLC)(B=0.081, P=0.028) after calibrating confounders. Multivariate Logistic regression analysis showed that after calibrating confounders, hypertension (OR=4.1,5%CI:2.034~18.117), diabetes (OR=1.0,5%CI:1.158~3.645), PAI-1 level (OR=1.1,5%CI:1.039~1.145), moderate OSAHS (OR=1.7,5%CI:1.162~3.730), severe OSAHS (OR=5.4,5%CI:1.085~31.370) were independent risk factors for unstable carotid plaque in patients with OSAHS (P<0.05). Conclusion The level of PAI-1 might increase gradually accompanied by the severity of OSAHS and the level of PAI-1 might be positively correlated with CIMT. PAI-1 might be an independent risk factor for unstable arterial plaque in OSAHS.

    Reference
    [1] QASEEM A, HOLTY J E, OWENS D K, et al.Management of obstructive sleep apnea in adults:a clinical practice guideline from the American College of Physicians.Ann Intern Med, 3,9(7):471-483.
    [2] VEASEY S C, ROSEN I M.Obstructive sleep apnea in adults.N Engl J Med, 9,0(15):1442-1449.
    [3] LIU X M, MA Y M, OUYANG R Y, et al.The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome.J Neuroinflammation, 0,7(1):229.
    [4] SANDERSON J E, FANG F, LU M, et al.Obstructive sleep apnoea,intermittent hypoxia and heart failure with a preserved ejection fraction.Heart, 1,7(3):190-194.
    [5] DANDAN Z, SHEN C, LIU X, et al.IL-33/ST2 mediating systemic inflammation and neuroinflammation through NF-κB participated in the neurocognitive impairment in obstructive sleep apnea.Int Immunopharmacol, 2,5:109604.
    [6] KOJIC B, DOSTOVIC Z, IBRAHIMAGIC O C, et al.Risk factors in acute stroke patients with and without sleep apnea.Med Arch, 1,5(6):444-450.
    [7] SALARI N, KHAZAIE H, ABOLFATHI M, et al.The effect of obstructive sleep apnea on the increased risk of cardiovascular disease:a systematic review and Meta-analysis.Neurol Sci, 2,3(1):219-231.
    [8] 齐炳才, 靳琦文, 胡杰, 等.颈动脉粥样硬化斑块内新生血管的研究现状及进展.中国动脉硬化杂志, 1,9(4):359-362.QI B C, JIN Q W, HU J, et al.Research status and progress of carotid atherosclerotic intraplaque neovascularization.Chin J Arterioscler, 1,9(4):359-362.
    [9] BINDER BR, CHRIST G, GRUBER F, et al.Plasminogen activator inhibitor 1:physiological and pathophysiological roles.News Physiol Sci, 2,7:56-61.
    [10] DE TAEYE B, SMITH L H, VAUGHAN D E.Plasminogen activator inhibitor-1:a common denominator in obesity, diabetes and cardiovascular disease.Curr Opin Pharmacol, 5,5(2):149-154.
    [11] ZHAI J, LI Z, ZHOU Y, et al.The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases:an update review.J Reprod Immunol, 2,0:103490.
    [12] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等.成人阻塞性睡眠呼吸暂停基层诊疗指南(2018年).中华全科医师杂志, 9,8(1):21-29.Chinese Medical Association, Chinese Medical Jounals Publishig House, Chinese Society of General Practice, et al.Guideline for primary care of adult obstructive sleep apnea (2018).Chin J Gen Pract, 9,8(1):21-29.
    [13] GAN Y, WU J, LI L Q, et al.Association of smoking with risk of stroke in middle-aged and older Chinese:evidence from the China national stroke prevention project.Medicine (Baltimore), 8,7(47):e13260.
    [14] WHELTON P K, CAREY R M, ARONOW W S, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults:a report of the American college of cardiology/American heart association task force on clinical practice guidelines.J Am Coll Cardiol, 8,1(19):e127-e248.
    [15] American Diabetes Association.Diagnosis and classification of diabetes mellitus.Diabetes Care, 0,3 Suppl 1(Suppl 1):S62-S69.
    [16] BERRY R B, BUDHIRAJA R, GOTTLIEB D J, et al.Rules for scoring respiratory events in sleep:update of the 2007 AASM manual for the scoring of sleep and associated events.Deliberations of the sleep apnea definitions task force of the American academy of sleep medicine.J Clin Sleep Med, 2,8(5):597-619.
    [17] SHINOZAKI N, OGATA N, IKARI Y.Plaque protrusion detected by intravascular ultrasound during carotid artery stenting.J Stroke Cerebrovasc Dis, 4,3(10):2622-2625.
    [18] BAYMAN E O, DEXTER F.Multicollinearity in Logistic regression models.Anesth Analg, 1,3(2):362-365.
    [19] YAGGI H K, CONCATO J, KERNAN W N, et al.Obstructive sleep apnea as a risk factor for stroke and death.N Engl J Med, 5,3(19):2034-2041.
    [20] LIU X, LAM D C, MAK H K, et al.Associations of sleep apnea risk and oxygen desaturation indices with cerebral small vessel disease burden in patients with stroke.Front Neurol, 2,3:956208.
    [21] NEZU T, HOSOMI N, AOKI S, et al.Carotid intima-media thickness for atherosclerosis.J Atheroscler Thromb, 6,3(1):18-31.
    [22] HAO Z L, QIN L, TONG J Y, et al.The differences of carotid atherosclerosis among non-OSAHS and OSAHS patients of different severities:a cross-sectional study.Sleep Breath, 1,5(2):639-648.
    [23] DELLAS C, LOSKUTOFF D J.Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease.Thromb Haemost, 5,3(4):631-640.
    [24] SPRENGERS E D, KLUFT C.Plasminogen activator inhibitors.Blood, 7,9(2):381-387.
    [25] JNSSON RYLANDER A C, LINDGREN A, DEINUM J, et al.Fibrinolysis inhibitors in plaque stability:a morphological association of PAI-1 and TAFI in advanced carotid plaque.J Thromb Haemost, 7,5(4):758-769.
    [26] TOFF W D, JONES C I, FORD I.Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation.J Vasc Surg, 6,4(4):910.
    [27] LIAO H, HYMAN M C, LAWRENCE D A, et al.Molecular regulation of the PAI-1 gene by hypoxia:contributions of Egr-1,HIF-1alpha,and C/EBPalpha.FASEB J, 7,1(3):935-949.
    [28] 王亚南, 黄引芳, 杨露, 等.阻塞性睡眠呼吸暂停低通气综合征患者颈动脉内膜中膜厚度及其与外周血25羟维生素D水平的关系.中国动脉硬化杂志, 0,8(10):890-894.WANG Y N, HUANG Y F, YANG L, et al.Carotid intima-media thickness and its correlation with 25 (OH)D in obstructive sleep apnea hypopnea syndrome patients.Chin J Arterioscler, 0,8(10):890-894.
    [29] SALMAN L A, SHULMAN R, COHEN J B.Obstructive sleep apnea, hypertension, and cardiovascular risk:epidemiology, pathophysiology, and management.Curr Cardiol Rep, 0,2(2):6.
    [30] PICARD F, PANAGIOTIDOU P, WEINIG L, et al.Effect of CPAP therapy on nocturnal blood pressure fluctuations, nocturnal blood pressure, and arterial stiffness in patients with coexisting cardiovascular diseases and obstructive sleep apnea.Sleep Breath, 1,5(1):151-161.
    Related
    Cited by
Get Citation

CHEN Dan, LUO Dong. Correlation between serum plasminogen activator inhibitor-1 level and carotidintima-media thickness, plaque stability in patients with obstructive sleep apnea hypopnea syndrome[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2023,31(8):697-704.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 08,2022
  • Revised:March 10,2023
  • Online: July 20,2023
Article QR Code